We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights Meta Platforms, Becton Dickinson, CME Group, Chipotle Mexican Grill and ParkerHannifin
Read MoreHide Full Article
For Immediate Release
Chicago, IL – November 10, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Meta Platforms, Inc. (META - Free Report) , Becton, Dickinson and Co. (BDX - Free Report) , CME Group (CME - Free Report) , Chipotle Mexican Grill (CMG - Free Report) and ParkerHannifin (PH - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Top Analyst Reports for Meta, Bescton Dickingson and CME Group
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc., Becton, Dickinson and Co. and CME Group. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Shares of Meta Platforms have underperformed the Zacks Internet - Software industry over the past year (-70.6% vs. -68.5%). The company is suffering from challenging macroeconomic conditions that are negatively impacting its advertising spending. Unfavorable forex, targeting and measurement headwinds due to Apple’s iOS changes, normalization of e-commerce after the pandemic peak and higher inflation hurt growth in the reported quarter.
User base in Europe declined in the quarter, as well. Meta’s third-quarter guidance reflects macroeconomic and forex concerns. Weak advertising demand is another headwind. Meta expects Reels to monetize much slower than Feed or Stories.
However, Meta is benefiting from steady user growth across all regions, particularly Asia Pacific. Increased engagement for its products like Instagram, WhatsApp, Messenger and Facebook has been a major growth driver.
Becton, Dickinson’s shares have declined -10.7% over the past year against the Zacks Medical - Dental Supplies industry’s decline of -15.2%. The year-over-year fall in BD Life Sciences and international revenues is worrying. Lower COVID-only testing revenues are discouraging from a business perspective. BD’s operations in a highly consolidated medical technology industry and a stiff competitive space are worrying. Forex woes prevail.
However, improvement on its overall top line and base revenues in third-quarter fiscal 2022 is impressive. Robust results by a majority of the arms and in the U.S. are promising. Expansion of both margins is a plus.
A raised financial outlook for the full fiscal year is also promising. Regulatory approvals and launches are encouraging. BD’s strategic deals augur well. A strong solvency position is an added plus. BD’s fiscal third-quarter results were better than expected.
CME Group’s shares have declined -21.6% over the past year against the Zacks Securities and Exchanges industry’s decline of -37.7%. The company is facing escalating expenses due to higher technology costs that are likely to put pressure on the company's margin expansion.
Diversified product portfolio is significantly exposed to volatile interest rate, firm government regulations and limited credit availability in unstable capital and credit markets. Also, stiff competition poses financial risk for the company.
However, CME Group’s strong market position driven by varied derivative product lines bodes well. Efforts to expand and cross sell through strategic alliances, acquisitions, new product initiatives and a stable global presence bode well.
Product innovation and growing proportion of volume from customers outside the U.S. have been aiding results. The company intends to focus more on over-the-counter clearing services.
Other noteworthy reports we are featuring today include Chipotle Mexican Grill and ParkerHannifin.
Why Haven’t You Looked at Zacks' Top Stocks?
Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights Meta Platforms, Becton Dickinson, CME Group, Chipotle Mexican Grill and ParkerHannifin
For Immediate Release
Chicago, IL – November 10, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Meta Platforms, Inc. (META - Free Report) , Becton, Dickinson and Co. (BDX - Free Report) , CME Group (CME - Free Report) , Chipotle Mexican Grill (CMG - Free Report) and ParkerHannifin (PH - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Top Analyst Reports for Meta, Bescton Dickingson and CME Group
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc., Becton, Dickinson and Co. and CME Group. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Shares of Meta Platforms have underperformed the Zacks Internet - Software industry over the past year (-70.6% vs. -68.5%). The company is suffering from challenging macroeconomic conditions that are negatively impacting its advertising spending. Unfavorable forex, targeting and measurement headwinds due to Apple’s iOS changes, normalization of e-commerce after the pandemic peak and higher inflation hurt growth in the reported quarter.
User base in Europe declined in the quarter, as well. Meta’s third-quarter guidance reflects macroeconomic and forex concerns. Weak advertising demand is another headwind. Meta expects Reels to monetize much slower than Feed or Stories.
However, Meta is benefiting from steady user growth across all regions, particularly Asia Pacific. Increased engagement for its products like Instagram, WhatsApp, Messenger and Facebook has been a major growth driver.
(You can read the full research report on Meta Platforms here >>>)
Becton, Dickinson’s shares have declined -10.7% over the past year against the Zacks Medical - Dental Supplies industry’s decline of -15.2%. The year-over-year fall in BD Life Sciences and international revenues is worrying. Lower COVID-only testing revenues are discouraging from a business perspective. BD’s operations in a highly consolidated medical technology industry and a stiff competitive space are worrying. Forex woes prevail.
However, improvement on its overall top line and base revenues in third-quarter fiscal 2022 is impressive. Robust results by a majority of the arms and in the U.S. are promising. Expansion of both margins is a plus.
A raised financial outlook for the full fiscal year is also promising. Regulatory approvals and launches are encouraging. BD’s strategic deals augur well. A strong solvency position is an added plus. BD’s fiscal third-quarter results were better than expected.
(You can read the full research report on Becton, Dickinson here >>>)
CME Group’s shares have declined -21.6% over the past year against the Zacks Securities and Exchanges industry’s decline of -37.7%. The company is facing escalating expenses due to higher technology costs that are likely to put pressure on the company's margin expansion.
Diversified product portfolio is significantly exposed to volatile interest rate, firm government regulations and limited credit availability in unstable capital and credit markets. Also, stiff competition poses financial risk for the company.
However, CME Group’s strong market position driven by varied derivative product lines bodes well. Efforts to expand and cross sell through strategic alliances, acquisitions, new product initiatives and a stable global presence bode well.
Product innovation and growing proportion of volume from customers outside the U.S. have been aiding results. The company intends to focus more on over-the-counter clearing services.
(You can read the full research report on CME Group here >>>)
Other noteworthy reports we are featuring today include Chipotle Mexican Grill and ParkerHannifin.
Why Haven’t You Looked at Zacks' Top Stocks?
Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.